The Pulse of the MedTech Industry Report 2024 from EY is now available for download! While research shows that the MedTech industry is still growing, it is increasingly walking a narrow path between converging top-line and bottom-line pressures. With deep insights from EY thought leaders and perspectives from top MedTech executives on the current financing environment, capital efficiency viewpoints, what’s next in MedTech financing, and the future of innovation, the EY analysis on the state of the industry leaves no stone unturned.
Click here for details: www.ey.com/pulse
Related Reading
News / Global & Trade
Medtech POV Podcast: Rep. Brad Wenstrup on COVID-19 Lessons, Common Sense in Health Care, and Treating Shooting Victim Scalise
February 12, 2025
On the Medtech POV podcast, AdvaMed President and CEO Scott Whitaker sat down with recently retired U.S. Rep. Brad Wenstrup of Ohio, discussing lessons learned from the COVID-19 pandemic, illogical budgetary scoring of health care procedures, and Wenstrup’s life-saving triage of U.S. House of Representatives Majority Leader Steve Scalise after a shooting.
News / Global & Trade
AdvaMed Seeks Medical Technology Exemption from All Tariffs
February 1, 2025
AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
News / Global & Trade
AdvaMed Welcomes India, New Member Countries from Latin America, Middle East, Africa to IMDRF
October 10, 2024
The International Medical Device Regulators Forum (IMDRF) consists of medical device regulators from around the world that voluntarily convene to harmonize the regulatory requirements for medical products varying from country to country. The U.S. FDA is the Chair and Secretariat of the IMDRF for 2024 and recently hosted its 26th session. The IMDRF added 15 new affiliate members this year (Botswana, Costa Rica, Dominican Republic, El Salvador, Ethiopia, Kenya, India, Jordan, México, Oman, Nigeria, Paraguay, Peru, Tanzania, and Zimbabwe).
News / Code of Ethics / Global & Trade
AdvaMed Welcomes APEC Recommendations for Enterprise Integrity and Public Procurement
September 23, 2024
News / Global & Trade
AdvaMed Signs New MOU with British Medtech Association
June 26, 2024
AdvaMed, the Medtech Association, signed a renewed memorandum of understanding with the Association of British HealthTech Industries (ABHI) to strengthen the relationship between two of the leading medtech organizations in the world.
News / Global & Trade
AdvaMed Statement on FDA-USAID India Regulatory Session
April 16, 2024
AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring medical technology reaches patients. The event, called “Minds to Markets: Regulatory Considerations in Med-Tech,” advances US-India cooperation on medtech supply chain through greater regulatory alignment.
News / Global & Trade
AdvaMed Statement on the World Trade Organization Ministerial Conference
March 1, 2024
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
News / Global & Trade / Medical Imaging
AdvaMed Statement on the Sale and Privatization of the Federal Helium Reserve
January 22, 2024
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply chain disruptions are resolved.